Study period 2001-3 | Study period 2005-7 | P-value1 | ||
---|---|---|---|---|
Time to first blood product | min | 85 (33-151) | 26 (2-72) | < 0.001 |
RBC 0-6 h | n | 4 (2-10) | 5 (2-12) | 0.280 |
RBC total | n | 5 (2-10) | 5 (3-12) | 0.355 |
FFP 0-6 h | n | 0 (0-4) | 3 (0-10) | < 0.001 |
FFP total | n | 0 (0-4) | 3 (0-10) | < 0.001 |
PLT 0-6 h | n | 0 (0-0) | 1 (0-4) | < 0.001 |
PLT total | n | 0 (0-0) | 1 (0-4) | < 0.001 |
FFP:RBC 0-6 h | ratio2 | 0 (0-0.33) | 0.56 (0-0.83) | < 0.001 |
FFP:RBC total | ratio2 | 0 (0-0.36) | 0.60 (0-0.83) | < 0.001 |
PLT:RBC 0-6 h | ratio2 | 0 (0-0) | 0.17 (0-0.33) | < 0.001 |
PLT:RBC total | ratio2 | 0 (0-0) | 0.17 (0-0.33) | < 0.001 |
PLT:FFP 0-6 h | ratio2 | 0 (0-0.09) | 0.40 (0.21-0.43) | < 0.001 |
PLT:FFP total | ratio2 | 0 (0-0.14) | 0.40 (0.2-0.47) | < 0.001 |